Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026



Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Turnaround Specialist!!
View:
Post by socksnblonds642 on Aug 20, 2021 9:38am

Turnaround Specialist!!

He seems to be a turnaround specialist. Is this to turnaround a division that hasn't made a profit in many years. I doubt it it's just for that. As a turnaround specialist he's come in with a new set of eyes and will change staff, maybe already has. It's going to take time to identify these changes and implement by way of new hire amd then time for the new staff to get going. Should be ready just in time for the trail results a year and half away. All IMO. Could be a transition to a partnership and we take our $2 and find another investment or it's to build a strong team for what they know are good results and the windfall we all want. Time will tell. It's been mentioned here, more news to come that should yield some transparency. Maybe...
Comment by riverrrow on Aug 20, 2021 9:57am
Judging by the downward price action one or more shareholders may find the hiring of a turnaround specialist a bit disconcerting. I on the other hand bought more shares and warrants in the downward spiral. How smart am I? GLTA.
Comment by Pandora on Aug 20, 2021 10:14am
Not sure it says anything about how smart you are - time will tell on that - but it does suggest you have a lot more "disposable" income than many of us.
Comment by gonefishing2022 on Aug 20, 2021 10:26am
Just the way it goes I bought yesterday..Oh well
Comment by Rumpl3StiltSkin on Aug 20, 2021 10:04am
Yeah S&B, I see Shawn's removal as a positive. He wasn't exactly setting the world on fire. That this new COO/CEO is a turn around guy is great. :-)
Comment by baystock1 on Aug 20, 2021 4:13pm
Its likely the hiring of this new COO is what prompted Shawn's resignation as he could see the writing on the wall as in he was possibly about to be fired or demoted. Also to be fair to Shawn you get what you pay for and all of Theralase's big money and stock options are going to Roger and his proxy Kristina. While Shawn did have an important role we all know who was the real CEO behind ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     


Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250